International Wound Journal
© John Wiley & Sons Ltd and Medicalhelplines.com Inc.
Edited By: Keith Harding and Douglas Queen
Impact Factor: 2.594
ISI Journal Citation Reports © Ranking: 2015: 13/61 (Dermatology); 50/199 (Surgery)
Online ISSN: 1742-481X
The International Wound Journal has a strategic partnership with several companies. These are companies who provide strategic guidance to ensure it meets the needs of our readers. In addition, our strategic partners provide a financial commitment in the form of guaranteed advertising and subscriptions to aid the development and dissemination of the journal. Our strategic partners are:
Acelity is a global wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. We are committed to advancing the science of healing and restoring people’s lives. Available in more than 75 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,500 people around the world. We believe in enabling better futures for everyone. Please visit acelity.com.
To learn more about our offerings, click on one of the following links:
• KCI (including V.A.C.® Therapy, CelluTome™ Epidermal Harvesting System and GraftJacket® Regenerative Tissue Matrix)
• LifeCell (including AlloDerm® Regenerative Tissue Matrix and Strattice™ Reconstructive Tissue Matrix for plastic, reconstructive and general surgical applications)
• Systagenix (including PROMOGRAN PRISMA® collagen dressings, ADAPTIC® non adherent contact layers and TIELLE® foam dressings for hard to heal wounds like venous, arterial, pressure and diabetic foot ulcers)
Tissue Therapies Limited is a biomedical technology company developing significantly more effective treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. Tissue Therapies Limited is commercialising VitroGro® ECM, an extra-cellular matrix replacement for hard to heal wounds, primarily venous leg ulcers. Visit www.tissuetherapies.com to learn more about our company and products
If you're interested in finding out more about how to become a strategic partner please contact email@example.com